Update as of January 2, 2026: Pharmacies should know that the 340B Rebate Model Pilot Program (the Pilot), previously set to be in effect January 1, 2026 and that NCPA previously reported on and covered in this webinar, is currently paused. The information in this webinar pertaining to the Pilot is still relevant, but will not go into effect until a later time. NCPA will keep its members posted on developments.

As the Inflation Reduction Act continues to reshape drug pricing and reimbursement, the 340B program finds itself in the middle of a policy snowstorm. This timely session explores how the IRA's provisions—especially around Medicare price negotiations and manufacturer rebates—are impacting covered entities and contract pharmacies. Join us for a brisk walk through the latest developments, featuring insights from leading industry experts and a representative from a covered entity who will share real-world perspectives from the front lines. Whether you're navigating compliance, managing operations, or advocating for program sustainability, this session will help you stay ahead of the freeze.

Price

Members - Free

Non-Members -$45.00